Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $1.28 per share which beat the analyst consensus estimate of $0.94 by 36.17 percent. This is a 39.13 percent increase over earnings of $0.92 per share from the same period last year. The company reported quarterly sales of $261.300 million which beat the analyst consensus estimate of $248.406 million by 5.19 percent. This is a 30.33 percent increase over sales of $200.489 million the same period last year.